ReviewMedical2026

Controlling the uncontrollable? navigating naturalistic and controlled dosing in cannabis research.

Melendez S.; Chen M.; Pince C.; Bidwell L.; Bryan A. · Psychopharmacology · 2026

Research summary

**Background & Methods** This is a perspective review article examining methodological approaches in cannabis research, comparing controlled dose paradigms with naturalistic, self-administration study designs. The authors analyze the trade-offs between internal validity (controlled studies) and ecological validity (naturalistic studies) in assessing cannabis harms and benefits in human subjects. **Key Findings** • Controlled dose paradigms provide scientific rigor, precision, and regulatory alignment suitable for FDA approval processes, but fail to capture the complexity and variability of real-world cannabis consumption patterns, particularly regarding product types and administration methods. • Naturalistic study designs enhance ecological validity by reflecting actual legal market cannabis use and can inform policy decisions regarding high-THC concentrates and consumption guidelines, but introduce substantial variability, dosing challenges, and reproducibility concerns that complicate safety assessment and regulatory acceptance. • Rather than viewing these approaches as competing alternatives, controlled laboratory and naturalistic paradigms should be integrated within a comprehensive evidentiary framework, with each method addressing distinct scientific questions that the other cannot answer independently. **Dosage & Administration** Not reported. This review does not present original data on specific cannabis doses or administration routes, though it discusses the methodological challenges of standardizing dosing in both controlled and naturalistic research contexts. **Safety & Adverse Effects** Not reported. The article does not present original safety data or adverse effect findings. However, it identifies safety assessment and monitoring as key methodological challenges when incorporating naturalistic dosing paradigms, particularly regarding variable THC concentrations in legal market products. **Evidence Quality** This perspective article represents a narrative review of research methodology rather than a primary research study, constituting lower-level evidence (Level V). Key limitations include the lack of meta-analysis, systematic literature review framework, or empirical data synthesis. The article's strength lies in its conceptual framework for integrating complementary research approaches. The authors acknowledge inherent trade-offs in cannabis research design but do not resolve fundamental tensions between regulatory requirements for controlled studies and stakeholder demands for real-world applicability. The proposed integrated methods section offers theoretical guidance but lacks specific implementation protocols or empirical validation of hybrid approaches.

Summary generated by DeepWeed from the published abstract. See the original paper for full methods and results.

Journal
Psychopharmacology
Year
2026
Study type
Review
Read the original paper (DOI) ↗
Ask how this study fits the wider evidence — across 26,000+ papers.
Ask DeepWeed

More recent cannabis research

This page summarises published research for informational purposes only — it isn't medical advice. Always refer to the original publication for full methods, results and limitations.

← Back to home